CASP2 and Huntington disease: Specific deficits in behavioral flexibility are a key feature of the cognitive defects observed in human HD patients [56,57], and improvement of these symptoms in casp2-/-;YAC128 mice supports the idea that casp2 inhibition may have impact on neural function, leading to symptomatic benefit.